Millie
your market intelligence analyst
Search Results
Edit Save
1,045 results
RealClearHealth 10/15/2019 10:42
ATR today released a coalition letter signed by 70 groups and activists in opposition to the Pelosi drug pricing proposal to create a 95 percent tax on pharmaceutical manufacturers.As noted in the letter, this bill calls for a retroactive tax on sales that is imposed in addition to existing against income taxes:Under Speaker Pelosi's plan, pharmaceutical manufacturers would face a retroactive tax of up to 95 percent on the total sales of a drug (not net profits).
RealClearHealth 10/15/2019 10:42
You have probably heard about a so-called "vaping health crisis," complete with "horror stories" that are growing worse and worse. Over the past few months, more than 1,200 people have become sick and 29 have died from a mysterious acute lung disease. This has led national, state, and local politicians to demand bans on e-cigarettes to protect public health, often invoking emergency powers to implement them.
RealClearHealth 10/11/2019 10:40
The LA Times reports that drugmakers fought hard against California's groundbreaking drug price transparency law, passed in 2017. I'll bet they did! So what have we learned?Pharmaceutical companies raised the wholesale acquisition cost of their drugs the list price for wholesalers without discounts or rebates by a median of 25.8% from 2017 through the first quarter of 2019, according to the Office of Statewide Health Planning and Development. (The median is the point at which half the prices are higher and half are lower.)
RealClearHealth 10/11/2019 09:59
Nearly a decade ago, when lawmakers guided the American public into passing Obamacare, they were working hand-in-hand with big insurance companies. The insurance industry was a willing accomplice to the health care overhaul and aggressively lobbied Congress for a beneficial final product. The result was one of Obamacare's worst kept secrets: under the cloak of health care reform, insurance companies enjoyed a significant financial windfall.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications